X4 Pharmaceuticals, Inc. - Common Stock - estatísticas financeiras trimestrais (NASDAQ:XFOR) | MetaTrader

Abrir gráfico completo Full chart

Notícias

Bears are Losing Control Over X4 Pharmaceuticals (XFOR), Here's Why It's a 'Buy' Now

X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's What You Should Know

X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

X4 Pharmaceuticals recebe aprovação da UE para medicamento contra síndrome WHIM

Stifel reafirma classificação das ações da X4 Pharmaceuticals após progresso em ensaio clínico

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

X4 Pharmaceuticals na Leerink Global Healthcare Conference: mudança estratégica para hematologia rara

X4 Pharmaceuticals at Leerink Global Healthcare Conference: Strategic Shift to Rare Hematology

Guggenheim initiates X4 Pharmaceuticals stock with buy rating

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval